Sun Pharma continues rapid expansion in eye care technologies

Sun Pharmaceutical Industries in Mumbai, India, continues its rapid expansion into the ocular space with the announced acquisition of Ocular Technologies, whose lead candidate is the eye drop Seciera to treat dry eye disease, which is currently in a phase 3 clinical trial.Ocular Technologies Sarl is a portfolio company of Auven Therapeutics, an international private equity firm based primarily in Lausanne, Switzerland.